NCT03466814View on ClinicalTrials.gov

Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

April 6, 2018

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Undifferentiated Arthritis
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

162-0822

Local Institution, Shinjuku-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY